Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1

Status

Recruiting 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

NIH 9FED 9OTHER 5INDUSTRY 3

Study Type

Observational 21Interventional 5

Sponsor

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

tremelimumab 1durvalumab 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × Rare Diseases × Clear all
NCT06856902 2026-04-01

BEAMER

Technical University of Madrid

Phase NA Recruiting
3,100 enrolled

Treatment Adherence and Compliance, Cardiovascular Diseases, Neoplasms, Rare Diseases

NCT02938793 2025-09-23

Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors

Prisma Health-Upstate

Phase 2 Terminated
92 enrolled

Neoplasms, Rare Diseases

NCT06397443 2025-03-21

PaS

Istituto Ortopedico Rizzoli

Phase NA Completed
8 enrolled 28 charts

Psychological Well-Being, Enchondromatosis, Exostoses, Multiple Hereditary, Osteogenesis Imperfecta, Rare Diseases

NCT04760522 2023-11-29

GE-MED

University Hospital Tuebingen

Phase NA Recruiting
12,000 enrolled

Genetic Risk Score, Genetic Predisposition to Disease, Rare Diseases

NCT06060184 2023-09-29

IonGER

University Hospital Tuebingen

Phase NA Not yet recruiting
500 enrolled

Genetic Predisposition to Disease, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡